Influence of Aspirin and Ethanol on Fecal Blood Levels As Determined by Using the HemoQuant Assay

JON L. FLEMING, DAVID A. AHLQUIST, DOUGLAS B. McGILL, ALAN R. ZINSMEISTER, RALPH D. ELLEFSON, SAMUEL SCHWARTZ

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

We sought to determine the short-term effects of use of aspirin and ethanol on fecal occult blood levels measured with the HemoQuant assay. A factorial design was used to study 68 healthy volunteers randomized to receive various doses of aspirin, ethanol, or a combination of both for either 1 or 3 days. Fecal hemoglobin concentrations were measured before and after drug ingestions. Moderate quantities of ethanol (300 ml of 5% or 30 ml of 50% three times nightly) did not cause significant fecal blood elevation unless aspirin was administered concomitantly (P = 0.05). High-dose aspirin alone, 975 mg three times daily, induced abnormal blood loss (P<0.01). The highest HemoQuant levels were usually noted after concomitant administration of aspirin and ethanol at maximal doses for 3 days (P<0.005), some HemoQuant levels approaching 5 times the normal value. We conclude that, in a short-term analysis, social consumption of ethanol is unlikely to interfere with fecal blood testing but therapeutic doses of aspirin will.

Original languageEnglish (US)
Pages (from-to)159-163
Number of pages5
JournalMayo Clinic proceedings
Volume62
Issue number3
DOIs
StatePublished - 1987

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Influence of Aspirin and Ethanol on Fecal Blood Levels As Determined by Using the HemoQuant Assay'. Together they form a unique fingerprint.

Cite this